Product information

From Health Canada

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2015-11-20

Original market date: See footnote 1

1996-10-31

Product name:

CREON MINIMICROSPHERES 10

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

02200104

Product Monograph/Veterinary Labelling:

Date: 2023-08-21 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

BGP PHARMA ULC
85 Advance Road
Etobicoke
Ontario
Canada M8Z 2S6

Class:

Human

Dosage form(s):

Capsule (Delayed Release)

Route(s) of administration:

Oral

Number of active ingredient(s):

3

Schedule(s):

Prescription

 

American Hospital Formulary Service (AHFS): See footnote 3

56:16.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC)

Active ingredient group (AIG) number:See footnote5

0302964040

List of active ingredient(s)
Active ingredient(s) Strength
AMYLASE 11200 UNIT
LIPASE 10000 UNIT
PROTEASE 730 UNIT
Version 4.0.2
Date modified: